Featured
-
Breaking News | Clinical Trials | Industry News
SGS Initiates COVID-19 Clinical Trials in U.S.
Phase 2/3 trial will examine the safety, tolerability, and efficacy of Sarconeos (BIO101) to treat COVID-19 related respiratory failure.Contract Pharma Staff 11.30.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
APIs | Breaking News | Facilities | Industry News
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.Contract Pharma Staff 11.25.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
Manufacturing at Wacker’s biotech site in Amsterdam is scheduled to start in the first half of 2021.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Supply Chain
Lonza and Be The Match BioTherapies Enter CGT Partnership
Will expand Vein-to-Vein Cell and Gene Therapy Supply Chain Network.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | Facilities | Industry News
Samsung Biologics Breaks Ground on 'Super Plant'
When completed, the CDMO says it will be the world's largest bio-manufacturing facility.Contract Pharma Staff 11.24.20
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
ApiJect Systems Approved for $590 Million Loan
Supports building a U.S.-based facility with surge capacity to produce up to 3 billion single-dose prefilled plastic injectors per year.Contract Pharma Staff 11.24.20
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Syngene and 3DC Sign 5-year Collaboration
Partner on discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.Contract Pharma Staff 11.24.20
-
Drug Delivery | Drug Development
Inhaled Drug Delivery Technology Trends
The success of new inhaled medicines relies on the correct combination of formulation and device technology.Online Exclusives Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20
-
Breaking News | Facilities | Industry News
Abenza Upgrades Chemistry GMP Suites
Appoints new leadership at Bristol PA site.Contract Pharma Staff 11.24.20
-
Breaking News | Clinical Trials | Industry News
Merck Acquires OncoImmune for $425M
Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19.Contract Pharma Staff 11.24.20
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Fill/Finish | Industry News | Injectables | Lyophilization | Parenterals
Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
Construction currently underway; expected to be completed in 2021.Contract Pharma Staff 11.24.20
-
Pre-filled Syringes & Injectable Drug Trends
Pre-filled syringes have become a preferred format, as they make it easier to handle drugs and increase dos- ing accuracy.11.23.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AstraZeneca’s AZD1222 Meets Primary Endpoint in COVID-19
Two different dosing regimens demonstrated efficacy with one showing vaccine efficacy of 90% with no serious safety events noted.Contract Pharma Staff 11.23.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's COVID-19 Antibody Cocktail Gets EUA
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.Contract Pharma Staff 11.23.20
- SGS Initiates COVID-19 Clinical Trials in U.S.
- CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
- Merck Acquires OncoImmune for $425M
- ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
- Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
- Samsung Biologics Partners with Eli Lilly
- Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France
- Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study
- Almac Gets Grant From COVID-19 Therapeutics Accelerator
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- Vectura, Kinaset Partner to Develop Asthma Treatment
- SGS Initiates COVID-19 Clinical Trials in U.S.
- Lonza Expands Development, Mfg. Capabilities at Bend Site
- CordenPharma Colorado Increases US Peptide Manufacturing Capacity
- CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
- Lonza and Be The Match BioTherapies Enter CGT Partnership
- Samsung Biologics Breaks Ground on 'Super Plant'
- ApiJect Systems Approved for $590 Million Loan
- Syngene and 3DC Sign 5-year Collaboration
- Abenza Upgrades Chemistry GMP Suites
November/December 2020
- Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
- Ensuring Quality During the Transfer and Scale Up of Rx Drugs
- Inspecting the Unexpected
- Cold Chain Trends
- Catering for the Complex
- Biopharma Contract Manufacturing: Robust Growth Ahead
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- The Single-Use Mixing Landscape: Evaluating Your Options
- Self-Medication: Flexibility for Patients and Drug Manufacturers
- Decentralized Trials Fuel AI Revolution in Clinical Research
Contract Service Directory
Search the Directories for A Company:
Trending
- Baxter Invests $50M To Expand Sterile Fill/Finish Manufacturing Operations
- CureVac And Wacker Sign Contract For Manufacturing Of Covid-19 Vaccine Candidate
- Inhaled Drug Delivery Technology Trends
- CordenPharma Colorado Increases US Peptide Manufacturing Capacity
- India Emerges As Hot Spot For Manufacturing COVID-19 Vaccines
